Advertisement

The Lesson from the COMPANION Study: How Large Is the Patient Population That May Benefit?

  • E. G. Gronda
  • M. Mangiavacchi
  • D. Pini
  • L. Genovese
  • L. Tomaello
  • B. Andreuzzi
  • A. Municinò
Conference paper

Abstract

Nearly 5 million persons living in the United States have heart failure, with 550 000 new cases diagnosed annually. Heart failure is the only cardiovascular disease in which the prevalence is increasing; projections suggest that prevalence will increase two- to three-fold by the year 2010 [1]. This increase is probably the result of aging of the population and the successful treatment of acute coronary syndromes.

Keywords

Heart Failure Chronic Heart Failure Left Bundle Branch Block Advanced Heart Failure Left Ventricular Lead 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bonneaux L, Barendregt JJ, Meeter K et al (1994) Estimated clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure. Am J Public Health 84:20–28CrossRefGoogle Scholar
  2. 2.
    Stewart S, Maclntire K, Hole DJ, Capewell S, McMurray JJV (2001) More malignant than cancer? Five-year survival following a first hospital admission for heart failure. Eur J Heart failure 3:315–322CrossRefGoogle Scholar
  3. 3.
    Baldesseroni S, Opasich C, Gorini M et al (2002) Left bundle branch block is associated with increased 1 year sudden and total morality rate in 5517 outpatients with congestive heart failure: a report from the Italian Network on Congestive Heart failure. Am Heart J 143:398–405CrossRefGoogle Scholar
  4. 4.
    Bradley DJ, Bradley EA, Baughman KL et al (2003) Cardiac resynchronization and death from progressive heart failure. A meta-analysis of randomized controlled trials. JAMA 289:730–740PubMedCrossRefGoogle Scholar
  5. 5.
    Pitt B, Zannad F, Remme WJ et al (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341:709–717PubMedCrossRefGoogle Scholar
  6. 6.
    Whorlow SL, Krum H (2000) Meta-analysis of beta blocker therapy on mortality in patients with NYHA Class IV chronic congestive heart failure. Am J Cardiol 86:886–889PubMedCrossRefGoogle Scholar
  7. 7.
    Packer M (2001) Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. J Card Fail 7:176–182PubMedCrossRefGoogle Scholar
  8. 8.
    Packer M, Coats AJS, Fowler MB, Katus HA, Krum HB et al (2001) Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344:1651–1658PubMedCrossRefGoogle Scholar
  9. 9.
    Moss AJ, Zareba W, Hall JW (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 348:877–883CrossRefGoogle Scholar
  10. 10.
    Bristow MR, Feldman AM, Saxon LA, for the COMPANION Steering Committee and COMPANION Clinical Investigators (2000) Heart failure management using implan-table devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart failure (COMPANION) trial. J Card Fail 6:276–285PubMedCrossRefGoogle Scholar
  11. 11.
    Abraham WT, Fisher WG, Smith AL et al (2002) Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1845–1853PubMedCrossRefGoogle Scholar
  12. 12.
    Metcalfe C, Thompson SG, Cowie MR, Sharpies LD (2003) The use of hospital admission data as a measure of outcome in clinical studies of heart failure. Eur Heart J 24:105–112PubMedCrossRefGoogle Scholar
  13. 13.
    Gronda E, Mangiavacchi M, Andreuzzi B et al (2002) A population-based study on overt heart failure in Lombardy (survey of hospitalization in 1996 and 1997. Ital Heart J3(2):96–103Google Scholar
  14. 14.
    Bellotti P, Badano LP, Acquarone N et al, for the OSCUR Investigators (2001) Specialty related differences, in clinical profile management and outcome of patients hospitalized for heart failure: the OSCUR Study. Eur Heart J 22:596–604PubMedCrossRefGoogle Scholar
  15. 15.
    Ahmed A, Roseman JM, Duxbury AS et al (2002) Correlates and outcomes of preserved left ventricular systolic function among older adults hospitalized with heart failure. Am Heart J 144:365–372PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2004

Authors and Affiliations

  • E. G. Gronda
    • 1
  • M. Mangiavacchi
    • 1
  • D. Pini
    • 1
  • L. Genovese
    • 1
  • L. Tomaello
    • 1
  • B. Andreuzzi
    • 1
  • A. Municinò
    • 1
  1. 1.U.O. di Cardiologia Clinica e di Terapia dell’Insufficienza CardiacaIstituto Clinico HumanitasRozzano, MilanItaly

Personalised recommendations